{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:13:20Z","timestamp":1788812000479,"version":"build-2803163510"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Faculty of Science, Medicine and Health, University of Wollongong"},{"DOI":"10.13039\/100001458","name":"American Kennel Club Canine Health Foundation","doi-asserted-by":"publisher","award":["03181-A"],"award-info":[{"award-number":["03181-A"]}],"id":[{"id":"10.13039\/100001458","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001777","name":"The University of Wollongong","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001777","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Purinergic Signalling"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Peripheral blood mononuclear cells (PBMCs) are commonly cryopreserved for immune cell profiling analyses, like flow cytometry. Cryopreservation of PBMCs may affect the recovery of immune cell subsets or the presence of cell-surface molecules, potentially skewing results compared to freshly isolated PBMCs. The ectonucleotidase CD39 promotes immunosuppression through the hydrolysis of extracellular nucleotides such as adenosine 5\u2019-triphosphate (ATP) to limit P2X7 activation and downstream immune responses. Because of this, CD39 and P2X7 are emerging as potential biomarkers in cancer and other diseases. Using flow cytometry, this study demonstrated that an anti-human CD39 monoclonal antibody (mAb) (clone TU66) bound human embryonic kidney (HEK) 293 cells transfected with human CD39, but not mock-transfected HEK293 cells. In contrast, an anti-human P2X7 mAb (clone 1058613) bound similarly to HEK293 cells transfected with human P2X7 and non-transfected HEK293 cells. Using flow cytometry, this study then assessed the impact of cryopreservation on the population frequencies of immune cell subsets including CD39\n                    <jats:sup>+<\/jats:sup>\n                    cells in human PBMC samples. These analyses revealed that cryopreservation had a minor, yet statistically significant impact on the population frequencies of CD4\n                    <jats:sup>+<\/jats:sup>\n                    , CD8\n                    <jats:sup>+<\/jats:sup>\n                    and CD4\n                    <jats:sup>\u2212<\/jats:sup>\n                    CD8\n                    <jats:sup>\u2212<\/jats:sup>\n                    T cells. Cryopreservation also had a significant impact on the frequencies of CD39\n                    <jats:sup>+<\/jats:sup>\n                    CD19\n                    <jats:sup>+<\/jats:sup>\n                    B cells and CD39\n                    <jats:sup>+<\/jats:sup>\n                    non-classical monocytes. Overall, this study informs researchers and biobank workers about the need to consider the impact of cryopreservation when interpreting data from stored samples.\n                  <\/jats:p>","DOI":"10.1007\/s11302-026-10180-4","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T07:18:41Z","timestamp":1788765521000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of cryopreservation on immune cell subset frequencies in human peripheral blood mononuclear cells following assessment of monoclonal antibodies to CD39 and P2X7"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-1719-4847","authenticated-orcid":false,"given":"Leon","family":"Koning","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2085-8034","authenticated-orcid":false,"given":"Ashleigh","family":"Splitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8154-6966","authenticated-orcid":false,"given":"Daniel","family":"Brungs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin G.","family":"Carolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5915-7477","authenticated-orcid":false,"given":"Senthilkumar","family":"Gandhidasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4909-686X","authenticated-orcid":false,"given":"Ronald","family":"Sluyter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"key":"10180_CR1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.31564","volume":"14","author":"AN Jaiswal","year":"2022","unstructured":"Jaiswal AN, Vagga A (2022) Cryopreservation: a review article. Cureus 14:e31564. https:\/\/doi.org\/10.7759\/cureus.31564","journal-title":"Cureus"},{"key":"10180_CR2","doi-asserted-by":"publisher","DOI":"10.1177\/0963689721999617","volume":"30","author":"D Whaley","year":"2021","unstructured":"Whaley D, Damyar K, Witek RP, Mendoza A, Alexander M, Lakey JR (2021) Cryopreservation: an overview of principles and cell-specific considerations. Cell Transplant 30:963689721999617. https:\/\/doi.org\/10.1177\/0963689721999617","journal-title":"Cell Transplant"},{"key":"10180_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0022-1759(03)00202-3","volume":"278","author":"A Costantini","year":"2003","unstructured":"Costantini A, Mancini S, Giuliodoro S, Butini L, Regnery CM, Silvestri G, Montroni M (2003) Effects of cryopreservation on lymphocyte immunophenotype and function. J Immunol Methods 278:145\u2013155. https:\/\/doi.org\/10.1016\/S0022-1759(03)00202-3","journal-title":"J Immunol Methods"},{"key":"10180_CR4","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S0031-6997(25)06930-3","volume":"24","author":"G Burnstock","year":"1972","unstructured":"Burnstock G (1972) Purinergic nerves. Pharmacol Rev 24:509\u2013581","journal-title":"Pharmacol Rev"},{"key":"10180_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.immuni.2017.06.020","volume":"47","author":"F Di Virgilio","year":"2017","unstructured":"Di Virgilio F, Dal Ben D, Sarti AC, Giuliani AL, Falzoni S (2017) The P2X7 receptor in infection and inflammation. Immunity 47:15\u201331. https:\/\/doi.org\/10.1016\/j.immuni.2017.06.020","journal-title":"Immunity"},{"key":"10180_CR6","first-page":"229","volume-title":"ATP: from neurotransmission to cancer therapy","author":"RA Turcitu","year":"2026","unstructured":"Turcitu RA, Dizaji SR, Ouattara AK, Salarpour F, Danvid\u00e9 OG, Manzoni AG, Kammoe RBB, Gelsleichter NE, Purohit A, Salesse C, S\u00e9vigny J (2026) Nucleoside triphosphate diphosphohydrolases in extracellular nucleotide regulation: activity, structural insights, and pathophysiological implications. In: Sluyter R, Cederholm JME, Stokes L, Ulrich H, Vlajkovic SM, Tang Y (eds) ATP: from neurotransmission to cancer therapy. Elsevier Science & Technology, pp 229\u2013270"},{"key":"10180_CR7","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/j.0022-202X.2005.23857.x","volume":"125","author":"JG Georgiou","year":"2005","unstructured":"Georgiou JG, Skarratt KK, Fuller SJ, Martin CJ, Christopherson RI, Wiley JS, Sluyter R (2005) Human epidermal and monocyte-derived Langerhans cells express functional P2X receptors. J Invest Dermatol 125:482\u2013490. https:\/\/doi.org\/10.1111\/j.0022-202X.2005.23857.x","journal-title":"J Invest Dermatol"},{"key":"10180_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02524","volume":"10","author":"R Zhao","year":"2019","unstructured":"Zhao R, Qiao J, Zhang X, Zhao Y, Meng X, Sun D, Peng X (2019) Toll-like receptor-mediated activation of CD39 internalization in BMDCs leads to extracellular ATP accumulation and facilitates P2X7 receptor activation. Front Immunol 10:2524. https:\/\/doi.org\/10.3389\/fimmu.2019.02524","journal-title":"Front Immunol"},{"key":"10180_CR9","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1002\/eji.200940008","volume":"40","author":"SA L\u00e9vesque","year":"2010","unstructured":"L\u00e9vesque SA, Kukulski F, Enjyoji K, Robson SC, S\u00e9vigny J (2010) NTPDase1 governs P2X7-dependent functions in murine macrophages. Eur J Immunol 40:1473\u20131485. https:\/\/doi.org\/10.1002\/eji.200940008","journal-title":"Eur J Immunol"},{"key":"10180_CR10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12964-014-0040-7","volume":"12","author":"M Kuhny","year":"2014","unstructured":"Kuhny M, Hochd\u00f6rfer T, Ayata CK, Idzko M, Huber M (2014) CD39 is a negative regulator of P2X7-mediated inflammatory cell death in mast cells. Cell Commun Signal 12:40. https:\/\/doi.org\/10.1186\/s12964-014-0040-7","journal-title":"Cell Commun Signal"},{"key":"10180_CR11","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.jhep.2017.05.021","volume":"67","author":"LEB Savio","year":"2017","unstructured":"Savio LEB, de Andrade Mello P, Figliuolo VR, de Avelar Almeida TF, Santana PT, Oliveira SDS, Silva CLM, Feldbr\u00fcgge L, Csizmadia E, Minshall RD, Longhi MS, Wu Y, Robson SC, Coutinho-Silva R (2017) CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury. J Hepatol 67:716\u2013726. https:\/\/doi.org\/10.1016\/j.jhep.2017.05.021","journal-title":"J Hepatol"},{"key":"10180_CR12","doi-asserted-by":"publisher","unstructured":"Almeida-Santos G, Santiago-Carvalho I, Almeida FM, Barbosa Bomfim CC, Santos E Silva JC, Cantarini DG, Silva CR, Ribeiro MS, do Nascimento RS, de Gois Macedo B, Lisboa Raeder PH, Teixeira-Xavier Junior J, Alvarez JM, Hirata MH, Coutinho-Silva R, Robson SC, Amaral EP, Lasunskaia E, D'Imp\u00e9rio Lima MR (2026) CD39 regulates P2RX7-mediated lung necrotic lesions in severe experimental tuberculosis. Mucosal Immunol S1933-0219(26)00031-0. https:\/\/doi.org\/10.1016\/j.mucimm.2026.03.007","DOI":"10.1016\/j.mucimm.2026.03.007"},{"key":"10180_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2249.2012.04623.x","volume":"171","author":"FS Regateiro","year":"2013","unstructured":"Regateiro FS, Cobbold SP, Waldmann H (2013) CD73 and adenosine generation in the creation of regulatory microenvironments. Clin Exp Immunol 171:1\u20137. https:\/\/doi.org\/10.1111\/j.1365-2249.2012.04623.x","journal-title":"Clin Exp Immunol"},{"key":"10180_CR14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s43556-025-00345-9","volume":"6","author":"J Shen","year":"2025","unstructured":"Shen J, Liao B, Gong L, Li S, Zhao J, Yang H, Gong Y, Li Y (2025) CD39 and CD73: biological functions, diseases and therapy. Mol Biomed 6:97. https:\/\/doi.org\/10.1186\/s43556-025-00345-9","journal-title":"Mol Biomed"},{"key":"10180_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107055","volume":"89","author":"J Zeng","year":"2020","unstructured":"Zeng J, Ning Z, Wang Y, Xiong H (2020) Implications of CD39 in immune-related diseases. Int Immunopharmacol 89:107055. https:\/\/doi.org\/10.1016\/j.intimp.2020.107055","journal-title":"Int Immunopharmacol"},{"key":"10180_CR16","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.it.2016.04.009","volume":"37","author":"MC Takenaka","year":"2016","unstructured":"Takenaka MC, Robson S, Quintana FJ (2016) Regulation of the T cell response by CD39. Trends Immunol 37:427\u2013439. https:\/\/doi.org\/10.1016\/j.it.2016.04.009","journal-title":"Trends Immunol"},{"key":"10180_CR17","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.2217\/fon-2023-0871","volume":"20","author":"N Kaplinsky","year":"2024","unstructured":"Kaplinsky N, Williams K, Watkins D, Adams M, Stanbery L, Nemunaitis J (2024) Regulatory role of CD39 and CD73 in tumor immunity. Future Oncol 20:1367\u20131380. https:\/\/doi.org\/10.2217\/fon-2023-0871","journal-title":"Future Oncol"},{"key":"10180_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1547929","volume":"16","author":"L Almada","year":"2025","unstructured":"Almada L, Gazzoni YN, Beccaria CG, Fiocca Vernengo F, Boccardo S, Gorosito Serr\u00e1n M, Trivedi A, Vinuesa CG, Robson SC, Acosta Rodr\u00edguez EV, Gaya M, Montes CL, Gruppi A (2025) CD39 is an antibody-secreting B-cell marker that modulates germinal center and antibody responses during infection. Front Immunol 16:1547929. https:\/\/doi.org\/10.3389\/fimmu.2025.1547929","journal-title":"Front Immunol"},{"key":"10180_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/cells15090795","volume":"15","author":"A Elhage","year":"2026","unstructured":"Elhage A, Gunasegaran B, Smith N, Turner RJ, Watson D, McGuire HM, Sluyter R (2026) Mass cytometry reveals comparable proportions of leukocyte subsets and cell surface P2X7 or CD39 on human peripheral blood mononuclear cell samples isolated by Ficoll-Paque or SepMate tube density gradient centrifugation. Cells 15:795. https:\/\/doi.org\/10.3390\/cells15090795","journal-title":"Cells"},{"key":"10180_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jim.2016.02.004","volume":"431","author":"W Zhang","year":"2016","unstructured":"Zhang W, Nilles TL, Johnson JR, Margolick JB (2016) The effect of cellular isolation and cryopreservation on the expression of markers identifying subsets of regulatory T cells. J Immunol Methods 431:31\u201337. https:\/\/doi.org\/10.1016\/j.jim.2016.02.004","journal-title":"J Immunol Methods"},{"key":"10180_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-36121-9","volume":"8","author":"JU Hermansen","year":"2018","unstructured":"Hermansen JU, Tj\u00f8nnfjord GE, Munthe LA, Task\u00e9n K, Sk\u00e5nland SS (2018) Cryopreservation of primary B cells minimally influences their signaling responses. Sci Rep 8:17651. https:\/\/doi.org\/10.1038\/s41598-018-36121-9","journal-title":"Sci Rep"},{"key":"10180_CR22","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s11302-020-09714-1","volume":"16","author":"RJ Turner","year":"2020","unstructured":"Turner RJ, Geraghty NJ, Williams JG, Ly D, Brungs D, Carolan MG, Guy TV, Watson D, de Leon JF, Sluyter R (2020) Comparison of peripheral blood mononuclear cell isolation techniques and the impact of cryopreservation on human lymphocytes expressing CD39 and CD73. Purinergic Signal 16:389\u2013401. https:\/\/doi.org\/10.1007\/s11302-020-09714-1","journal-title":"Purinergic Signal"},{"key":"10180_CR23","doi-asserted-by":"publisher","first-page":"711","DOI":"10.4049\/immunohorizons.2100049","volume":"5","author":"CM Capelle","year":"2021","unstructured":"Capelle CM, Cir\u00e9 S, Ammerlaan W, Konstantinou M, Balling R, Betsou F, Cosma A, Ollert M, Hefeng FQ (2021) Standard peripheral blood mononuclear cell cryopreservation selectively decreases detection of nine clinically relevant T cell markers. ImmunoHoriz 5:711\u2013720. https:\/\/doi.org\/10.4049\/immunohorizons.2100049","journal-title":"ImmunoHoriz"},{"key":"10180_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24119465","volume":"24","author":"F Di Virgilio","year":"2023","unstructured":"Di Virgilio F, Vultaggio-Poma V, Falzoni S, Giuliani AL (2023) The coming of age of the P2X7 receptor in diagnostic medicine. Int J Mol Sci 24:9465. https:\/\/doi.org\/10.3390\/ijms24119465","journal-title":"Int J Mol Sci"},{"key":"10180_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0093058","volume":"9","author":"A Bhaskaracharya","year":"2014","unstructured":"Bhaskaracharya A, Dao-Ung P, Jalilian I, Spildrejorde M, Skarratt KK, Fuller SJ, Sluyter R, Stokes L (2014) Probenecid blocks human P2X7 receptor-induced dye uptake via a pannexin-1 independent mechanism. PLoS ONE 9:e93058. https:\/\/doi.org\/10.1371\/journal.pone.0093058","journal-title":"PLoS ONE"},{"key":"10180_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15092263","volume":"15","author":"A Elhage","year":"2023","unstructured":"Elhage A, Cuthbertson P, Sligar C, Watson D, Sluyter R (2023) A species-specific anti-human P2X7 monoclonal antibody reduces graft-versus-host disease in humanised mice. Pharmaceutics 15:2263. https:\/\/doi.org\/10.3390\/pharmaceutics15092263","journal-title":"Pharmaceutics"},{"key":"10180_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1577206","volume":"16","author":"AR Davies","year":"2025","unstructured":"Davies AR, Kwong K, Yu Z, Diamand KEM, Li F-J, Kannitha L, Ali SA, Amjadipour A, Padarin A-M, Devoy M, Vohra H, Miraghazadeh B, Jiang SH, Br\u00fcstle A, Cherbuin N, Nolan CJ, Cook MC, Gardiner EE, Read S, McNaughton E, Randall KL (2025) Advanced immunophenotyping of lymphocyte and monocyte subsets in healthy Australian adults using a novel spectral flow cytometry panel. Front Immunol 16:1577206. https:\/\/doi.org\/10.3389\/fimmu.2025.1577206","journal-title":"Front Immunol"},{"key":"10180_CR28","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1097\/MIB.0000000000000566","volume":"21","author":"DJ Gibson","year":"2015","unstructured":"Gibson DJ, Elliott L, McDermott E, Tosetto M, Keegan D, Byrne K, Martin ST, Rispens T, Cullen G, Mulcahy HE, Cheifetz AS, Moss AC, Robson SC, Doherty GA, Ryan EJ (2015) Heightened expression of CD39 by regulatory T lymphocytes is associated with therapeutic remission in inflammatory bowel disease. Inflamm Bowel Dis 21:2806\u20132814. https:\/\/doi.org\/10.1097\/MIB.0000000000000566","journal-title":"Inflamm Bowel Dis"},{"key":"10180_CR29","doi-asserted-by":"publisher","first-page":"11683","DOI":"10.1038\/s41598-017-12011-4","volume":"7","author":"L Kling","year":"2017","unstructured":"Kling L, Benck U, Breedijk A, Leikeim L, Heitzmann M, Porubsky S, Kr\u00e4mer BK, Yard BA, K\u00e4lsch AI (2017) Changes in CD73, CD39 and CD26 expression on T-lymphocytes of ANCA-associated vasculitis patients suggest impairment in adenosine generation and turn-over. Sci Rep 7:11683. https:\/\/doi.org\/10.1038\/s41598-017-12011-4","journal-title":"Sci Rep"},{"key":"10180_CR30","doi-asserted-by":"publisher","first-page":"588","DOI":"10.4049\/jimmunol.2400151","volume":"213","author":"JF Isaacs","year":"2024","unstructured":"Isaacs JF, Degefu HN, Chen T, Kleist SA, Musial SC, Ford MA, Searles TG, Lin CC, Skorput AGJ, Shirai K, Turk MJ, Zanazzi GJ, Rosato PC (2024) CD39 is expressed on functional effector and tissue-resident memory CD8+ T cells. J Immunol 213:588\u2013599. https:\/\/doi.org\/10.4049\/jimmunol.2400151","journal-title":"J Immunol"},{"key":"10180_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138375","volume":"10","author":"MK Abraham","year":"2015","unstructured":"Abraham MK, Nolte A, Reus R, Behring A, Zengerle D, Avci-Adali M, Hohmann JD, Peter K, Schlensak C, Wendel HP, Krajewski S (2015) In vitro study of a novel stent coating using modified CD39 messenger RNA to potentially reduce stent angioplasty-associated complications. PLoS ONE 10:e0138375. https:\/\/doi.org\/10.1371\/journal.pone.0138375","journal-title":"PLoS ONE"},{"key":"10180_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2021.796991","volume":"9","author":"E Tan","year":"2021","unstructured":"Tan E, Chin CSH, Lim ZFS, Ng SK (2021) HEK293 cell line as a platform to produce recombinant proteins and viral vectors. Front Bioeng Biotechnol 9:796991. https:\/\/doi.org\/10.3389\/fbioe.2021.796991","journal-title":"Front Bioeng Biotechnol"},{"key":"10180_CR33","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1152\/physiolgenomics.00195.2013","volume":"46","author":"M Spildrejorde","year":"2014","unstructured":"Spildrejorde M, Bartlett R, Stokes L, Jalilian I, Peranec M, Sluyter V, Curtis BL, Skarratt KK, Skora A, Bakhsh T, Seavers A, McArthur JD, Dowton M, Sluyter R (2014) R270C polymorphism leads to loss of function of the canine P2X7 receptor. Physiol Genomics 46:512\u2013522. https:\/\/doi.org\/10.1152\/physiolgenomics.00195.2013","journal-title":"Physiol Genomics"},{"key":"10180_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202451196","volume":"55","author":"A Elhage","year":"2025","unstructured":"Elhage A, Watson D, Sluyter R (2025) The anti-human P2X7 monoclonal antibody (clone L4) can mediate complement-dependent cytotoxicity of human leukocytes. Eur J Immunol 55:e202451196. https:\/\/doi.org\/10.1002\/eji.202451196","journal-title":"Eur J Immunol"},{"key":"10180_CR35","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.1182\/blood.V92.10.3521","volume":"92","author":"G Buell","year":"1998","unstructured":"Buell G, Chessell IP, Michel AD, Collo G, Salazzo M, Herren S, Gretener D, Grahames C, Kaur R, Kosco-Vilbois MH, Humphrey PP (1998) Blockade of human P2X7 receptor function with a monoclonal antibody. Blood 92:3521\u20133528. https:\/\/doi.org\/10.1182\/blood.V92.10.3521","journal-title":"Blood"},{"key":"10180_CR36","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2478\/jtim-2023-0136","volume":"12","author":"J Zhang","year":"2024","unstructured":"Zhang J, Yin Z, Liang Z, Bai Y, Zhang T, Yang J, Li X, Xue L (2024) Impacts of cryopreservation on phenotype and functionality of mononuclear cells in peripheral blood and ascites. J Transl Intern Med 12:51\u201363. https:\/\/doi.org\/10.2478\/jtim-2023-0136","journal-title":"J Transl Intern Med"},{"key":"10180_CR37","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1158\/1078-0432.CCR-18-2291","volume":"25","author":"JB Lee","year":"2019","unstructured":"Lee JB, Kang H, Fang L, D\u2019Souza C, Adeyi O, Zhang L (2019) Developing allogeneic double-negative T cells as a novel off-the-shelf adoptive cellular therapy for cancer. Clin Cancer Res 25:2241\u20132253. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-2291","journal-title":"Clin Cancer Res"},{"issue":"8","key":"10180_CR38","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.3324\/haematol.2017.186619","volume":"103","author":"A Roberto","year":"2018","unstructured":"Roberto A, Di Vito C, Zaghi E, Mazza EMC, Capucetti A, Calvi M, Tentorio P, Zanon V, Sarina B, Mariotti J, Bramanti S, Tenedini E, Tagliafico E, Bicciato S, Santoro A, Roederer M, Marcenaro E, Castagna L, Lugli E, Mavilio D (2018) The early expansion of anergic NKG2Apos\/CD56dim\/CD16neg natural killer represents a therapeutic target in haploidentical hematopoietic stem cell transplantation. Haematologica 103(8):1390\u20131402. https:\/\/doi.org\/10.3324\/haematol.2017.186619","journal-title":"Haematologica"},{"key":"10180_CR39","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.4049\/jimmunol.1701409","volume":"201","author":"A Tompa","year":"2018","unstructured":"Tompa A, Nilsson-Bowers A, Faresj\u00f6 M (2018) Subsets of CD4+, CD8+, and CD25hi lymphocytes are in general not influenced by isolation and long-term cryopreservation. J Immunol 201:1799\u20131809. https:\/\/doi.org\/10.4049\/jimmunol.1701409","journal-title":"J Immunol"},{"key":"10180_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2021.113081","volume":"495","author":"O Ticha","year":"2021","unstructured":"Ticha O, Moos L, Bekeredjian-Ding I (2021) Effects of long-term cryopreservation of PBMC on recovery of B cell subpopulations. J Immunol Methods 495:113081. https:\/\/doi.org\/10.1016\/j.jim.2021.113081","journal-title":"J Immunol Methods"},{"key":"10180_CR41","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jim.2018.11.006","volume":"465","author":"J Anderson","year":"2019","unstructured":"Anderson J, Toh ZQ, Reitsma A, Do LAH, Nathanielsz J, Licciardi PV (2019) Effect of peripheral blood mononuclear cell cryopreservation on innate and adaptive immune responses. J Immunol Methods 465:61\u201366. https:\/\/doi.org\/10.1016\/j.jim.2018.11.006","journal-title":"J Immunol Methods"},{"key":"10180_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-5-23","volume":"5","author":"D Pulte","year":"2007","unstructured":"Pulte D, Olson KE, Broekman MJ, Islam N, Ballard HS, Furman RR, Olson AE, Marcus AJ (2007) CD39 activity correlates with stage and inhibits platelet reactivity in chronic lymphocytic leukemia. J Transl Med 5:23. https:\/\/doi.org\/10.1186\/1479-5876-5-23","journal-title":"J Transl Med"},{"issue":"10","key":"10180_CR43","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1158\/2326-6066.CIR-20-0270","volume":"8","author":"KE Kortekaas","year":"2020","unstructured":"Kortekaas KE, Santegoets SJ, Sturm G, Ehsan I, van Egmond SL, Finotello F, Welters MJP, van Poelgeest MIE, van der Burg SH (2020) CD39 identifies the CD4+ tumor-specific T-cell population in human cancer. Cancer Immunol Res 8(10):1311\u20131321. https:\/\/doi.org\/10.1158\/2326-6066.CIR-20-0270","journal-title":"Cancer Immunol Res"},{"key":"10180_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/v16101609","volume":"16","author":"A Yero","year":"2024","unstructured":"Yero A, Shi T, Clain JA, Zghidi-Abouzid O, Racine G, Costiniuk CT, Routy JP, Estaquier J, Jenabian MA (2024) Double-negative T-cells during acute human immunodeficiency virus and simian immunodeficiency virus infections and following early antiretroviral therapy initiation. Viruses 16:1609. https:\/\/doi.org\/10.3390\/v16101609","journal-title":"Viruses"},{"key":"10180_CR45","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1097\/QAI.0000000000001266","volume":"74","author":"P Dierks","year":"2017","unstructured":"Dierks P, Wroblewski R, Eberhard JM, Martrus G, Degen O, Hertling S, Schmiedel S, Lunemann S, H\u00fcfner A, Lohse AW, Altfeld M, van Lunzen J, Schulze Zur Wiesch J (2017) Brief report: increased frequency of CD39+ CD56bright natural killer cells in HIV-1 infection correlates with immune activation and disease progression. J Acquir Immune Defic Syndr 74:467\u2013472. https:\/\/doi.org\/10.1097\/QAI.0000000000001266","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10180_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.946871","volume":"13","author":"S Qian","year":"2022","unstructured":"Qian S, Xiong C, Wang M, Zhang Z, Fu Y, Hu Q, Ding H, Han X, Shang H, Jiang Y (2022) CD38+CD39+ NK cells associate with HIV disease progression and negatively regulate T cell proliferation. Front Immunol 13:946871. https:\/\/doi.org\/10.3389\/fimmu.2022.946871","journal-title":"Front Immunol"},{"key":"10180_CR47","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2015.1082703","volume":"5","author":"F Figueir\u00f3","year":"2016","unstructured":"Figueir\u00f3 F, Muller L, Funk S, Jackson EK, Battastini AM, Whiteside TL (2016) Phenotypic and functional characteristics of CD39high human regulatory B cells (Breg). Oncoimmunology 5:e1082703. https:\/\/doi.org\/10.1080\/2162402X.2015.1082703","journal-title":"Oncoimmunology"},{"key":"10180_CR48","doi-asserted-by":"publisher","first-page":"134","DOI":"10.4049\/jimmunol.0803474","volume":"185","author":"H Moncrieffe","year":"2010","unstructured":"Moncrieffe H, Nistala K, Kamhieh Y, Evans J, Eddaoudi A, Eaton S, Wedderburn LR (2010) High expression of the ectonucleotidase CD39 on T cells from the inflamed site identifies two distinct populations, one regulatory and one memory T cell population. J Immunol 185:134\u2013143. https:\/\/doi.org\/10.4049\/jimmunol.0803474","journal-title":"J Immunol"},{"key":"10180_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0264566","volume":"17","author":"A C\u00e9rbulo-V\u00e1zquez","year":"2022","unstructured":"C\u00e9rbulo-V\u00e1zquez A, Garc\u00eda-Espinosa M, Briones-Gardu\u00f1o JC, Arriaga-Pizano L, Ferat-Osorio E, Zavala-Barrios B, Cabrera-Rivera GL, Miranda-Cruz P, Garc\u00eda de la Rosa MT, Prieto-Ch\u00e1vez JL, Rivero-Arredondo V, Madera-Sandoval RL, Cruz-Cruz A, Salazar-Rios E, Salazar-Rios ME, Serrano-Molina D, De Lira-Barraza RC, Villanueva-Compean AH, Esquivel-Pineda A, Ramirez-Montes de Oca R, L\u00f3pez-Mac\u00edas C (2022) The percentage of CD39+ monocytes is higher in pregnant COVID-19+ patients than in nonpregnant COVID-19+ patients. PLoS ONE 17:e0264566. https:\/\/doi.org\/10.1371\/journal.pone.0264566","journal-title":"PLoS ONE"},{"key":"10180_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1405249","volume":"15","author":"C Li","year":"2024","unstructured":"Li C, Xiao M, Geng S, Wang Y, Zeng L, Lai P, Gong Y, Chen X (2024) Comprehensive analysis of human monocyte subsets using full-spectrum flow cytometry and hierarchical marker clustering. Front Immunol 15:1405249. https:\/\/doi.org\/10.3389\/fimmu.2024.1405249","journal-title":"Front Immunol"},{"key":"10180_CR51","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13550-016-0232-5","volume":"6","author":"E Pardali","year":"2016","unstructured":"Pardali E, Schmitz T, Borgscheiper A, Iking J, Stegger L, Waltenberger J (2016) Cryopreservation of primary human monocytes does not negatively affect their functionality or their ability to be labelled with radionuclides: basis for molecular imaging and cell therapy. Eur J Nucl Med Mol Imaging Res 6:77. https:\/\/doi.org\/10.1186\/s13550-016-0232-5","journal-title":"Eur J Nucl Med Mol Imaging Res"}],"container-title":["Purinergic Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-026-10180-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11302-026-10180-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-026-10180-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:02:51Z","timestamp":1788811371000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11302-026-10180-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,7]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10180"],"URL":"https:\/\/doi.org\/10.1007\/s11302-026-10180-4","relation":{},"ISSN":["1573-9538","1573-9546"],"issn-type":[{"value":"1573-9538","type":"print"},{"value":"1573-9546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,7]]},"assertion":[{"value":"1 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experiments with human blood were conducted in accordance with approval by the Human Research Ethics Committee, University of Wollongong.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Informed, written consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","label":"Consent","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}],"article-number":"68"}}